GlaxoSmithKline inaugurates new vaccine manufacturing unit near Budapest
Budapest, May 30 (MTI) – Drugmaker GlaxoSmithKline (GSK) Biologicals inaugurated a new vaccine manufacturing unit in Gödöllő, on the outskirts of Budapest, on Monday.
Foreign Minister Péter Szijjártó said at the inauguration ceremony that in 2010 the Hungarian government set a new goal of making the country central Europe’s centre of production. He said the government had achieved considerable success in “reindustrialising” the economy, but Hungary must now become a centre for R+D and innovation.
He said the government tripled the amount of EU funds spent on R+D during the 2014-2020 funding period and the aim now is to increase R+D spending to 1.8 percent of GDP by 2020.
The pharmaceutical industry will have a key role to play in Hungary’s economic development, he said.
Photo: MTI
Source: http://mtva.hu/hu/hungary-matters
please make a donation here
Hot news
Nézőpont: Europeans shared surprising opinion about the EU’s crisis management
Király Thermal Bath: the iconic spa may regain its pomp with Turkish help – PHOTOS
Balázs Orbán: Guaranteeing Hungary’s security a priority
Why Choose Ecuador as Your Next Tourist Destination
What happened today in Hungary? — 18 April, 2024
Probe launched into suspected foreign financing attempt in Hungary